Shrm Bio-Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.21 M
as on 28-12-2024
- Paid Up Capital ₹ 1.21 M
as on 28-12-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 9.98 M
as on 28-12-2024
- Revenue -3.44%
(FY 2020)
- Profit 160.86%
(FY 2020)
- Ebitda 27.05%
(FY 2020)
- Net Worth 2.17%
(FY 2020)
- Total Assets 0.71%
(FY 2020)
About Shrm Bio-Technologies
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.21 M and a paid-up capital of Rs 1.21 M.
The company has closed loans amounting to ₹9.98 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kunal Vora and Priti Vora serve as directors at the Company.
- CIN/LLPIN
U40107WB2006PTC110903
- Company No.
110903
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2006
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Shrm Bio-Technologies Private Limited offer?
Shrm Bio-Technologies Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Medical Educational Service, Biotechnology Courses.
Who are the key members and board of directors at Shrm Bio-Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunal Vora  | Director | 29-Jan-2019 | Current |
| Priti Vora | Director | 29-Jul-2006 | Current |
Financial Performance of Shrm Bio-Technologies.
Shrm Bio-Technologies Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.44% decrease. The company also saw a substantial improvement in profitability, with a 160.86% increase in profit. The company's net worth moved up by a moderate rise of 2.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shrm Bio-Technologies?
In 2019, Shrm Bio-Technologies had a promoter holding of 85.56% and a public holding of 14.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹9.98 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2013 | State Bank Of India | ₹9.98 M | Satisfied |
How Many Employees Work at Shrm Bio-Technologies?
Unlock and access historical data on people associated with Shrm Bio-Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrm Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrm Bio-Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
